TrialThe Journal of clinical endocrinology and metabolism2024

Dasiglucagon for the Treatment of Congenital Hyperinsulinism: A Randomized Phase 3 Trial in Infants and Children.

Paul S Thornton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.